Market Closed -
NSE India S.E.
07:43:49 2024-04-26 am EDT
|
5-day change
|
1st Jan Change
|
309.8
INR
|
+0.65%
|
|
+3.03%
|
-13.09%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
3,293
|
1,713
|
783.1
|
3,405
|
19,024
|
16,166
|
Enterprise Value (EV)
1 |
6,682
|
5,150
|
4,196
|
6,757
|
22,644
|
19,753
|
P/E ratio
|
22.8
x
|
7.03
x
|
3.52
x
|
9.87
x
|
23.4
x
|
11.8
x
|
Yield
|
0.36%
|
0.7%
|
1.53%
|
0.35%
|
0.13%
|
0.15%
|
Capitalization / Revenue
|
0.51
x
|
0.22
x
|
0.12
x
|
0.5
x
|
1.78
x
|
1.16
x
|
EV / Revenue
|
1.04
x
|
0.67
x
|
0.62
x
|
1
x
|
2.12
x
|
1.42
x
|
EV / EBITDA
|
8.51
x
|
4.98
x
|
5.31
x
|
8.72
x
|
14.6
x
|
8.59
x
|
EV / FCF
|
-25
x
|
17.3
x
|
35.4
x
|
-27.8
x
|
-174
x
|
-132
x
|
FCF Yield
|
-4%
|
5.77%
|
2.82%
|
-3.6%
|
-0.57%
|
-0.76%
|
Price to Book
|
2.96
x
|
1.2
x
|
0.49
x
|
1.74
x
|
6.87
x
|
3.9
x
|
Nbr of stocks (in thousands)
|
59,730
|
59,730
|
59,730
|
59,730
|
59,730
|
59,730
|
Reference price
2 |
55.13
|
28.68
|
13.11
|
57.01
|
318.5
|
270.6
|
Announcement Date
|
5/30/18
|
6/4/19
|
7/20/20
|
6/19/21
|
6/21/22
|
7/19/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
6,430
|
7,694
|
6,767
|
6,787
|
10,690
|
13,910
|
EBITDA
1 |
785
|
1,035
|
789.5
|
774.5
|
1,552
|
2,300
|
EBIT
1 |
597.1
|
826.6
|
587.6
|
571.5
|
1,327
|
2,042
|
Operating Margin
|
9.29%
|
10.74%
|
8.68%
|
8.42%
|
12.41%
|
14.68%
|
Earnings before Tax (EBT)
1 |
221
|
374.9
|
303.1
|
340
|
1,123
|
1,854
|
Net income
1 |
144.2
|
243.6
|
222.3
|
344.9
|
813.9
|
1,366
|
Net margin
|
2.24%
|
3.17%
|
3.28%
|
5.08%
|
7.61%
|
9.82%
|
EPS
2 |
2.414
|
4.079
|
3.722
|
5.775
|
13.63
|
22.86
|
Free Cash Flow
1 |
-267.4
|
297.1
|
118.4
|
-243
|
-130.2
|
-150.1
|
FCF margin
|
-4.16%
|
3.86%
|
1.75%
|
-3.58%
|
-1.22%
|
-1.08%
|
FCF Conversion (EBITDA)
|
-
|
28.7%
|
15%
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
121.96%
|
53.27%
|
-
|
-
|
-
|
Dividend per Share
2 |
0.2000
|
0.2000
|
0.2000
|
0.2000
|
0.4000
|
0.4000
|
Announcement Date
|
5/30/18
|
6/4/19
|
7/20/20
|
6/19/21
|
6/21/22
|
7/19/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
3,389
|
3,437
|
3,413
|
3,352
|
3,620
|
3,587
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
4.317
x
|
3.321
x
|
4.323
x
|
4.328
x
|
2.332
x
|
1.559
x
|
Free Cash Flow
1 |
-267
|
297
|
118
|
-243
|
-130
|
-150
|
ROE (net income / shareholders' equity)
|
13.9%
|
19.2%
|
14.7%
|
19.4%
|
34.4%
|
39.5%
|
ROA (Net income/ Total Assets)
|
5.2%
|
6.72%
|
4.87%
|
4.74%
|
9.83%
|
13%
|
Assets
1 |
2,774
|
3,628
|
4,567
|
7,282
|
8,284
|
10,518
|
Book Value Per Share
2 |
18.60
|
23.80
|
26.80
|
32.80
|
46.40
|
69.40
|
Cash Flow per Share
2 |
0.2000
|
0.0500
|
0.6500
|
0.0500
|
0.0600
|
0.1100
|
Capex
1 |
330
|
253
|
261
|
545
|
833
|
1,174
|
Capex / Sales
|
5.14%
|
3.29%
|
3.86%
|
8.02%
|
7.79%
|
8.44%
|
Announcement Date
|
5/30/18
|
6/4/19
|
7/20/20
|
6/19/21
|
6/21/22
|
7/19/23
|
|
1st Jan change
|
Capi.
|
---|
| +5.14% | 103B | | -5.63% | 63.04B | | +39.52% | 39.06B | | +12.91% | 37.58B | | +7.41% | 33.24B | | +6.85% | 19.22B | | +12.86% | 16.83B | | +16.93% | 14.96B | | +7.73% | 15.03B |
Other Commodity Chemicals
|